Journal
TOPICS IN CLINICAL NUTRITION
Volume 35, Issue 2, Pages 168-177Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TIN.0000000000000215
Keywords
breast cancer; chemotherapy; feasibility; intermittent fasting; safety; toxicity
Categories
Ask authors/readers for more resources
Intermittent fasting has been shown to protect healthy cells from chemotherapy toxicity while sensitizing cancer cells, but the extent to which fasting is safe and feasible for individuals during chemotherapy is unknown. The studies reviewed demonstrate that for well-nourished women with breast cancer, intermittent fasting between 24 and 72 hours can be safe and feasible as determined by treatment side effects, blood work, adherence to a fasting protocol, and quality of life. Fasting is not without potential adverse side effects and limitations. Further research is needed to standardize optimal length of fasting and determine whether limited caloric intake is beneficial while fasting during chemotherapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available